Management's discussion and analysis of results of operations and financial condition highlights the importance of mobilizing and deploying IT-based resources in combination with leveraging the value of other resources and capabilities. The firm’s IT capabilities represent the application of physical or intangible IT resources such as technology, knowledge, practices, relationships, management skills, and business process understanding to further organizational goals. Our long-term success depends on our ability to continually discover or acquire, develop, and commercialize innovative medicines, which requires effective coordination of a firm’s assets and internal processes. The challenges inherent in pharmaceutical research and development, including the introduction of new products and indications, necessitate a robust IT capability to support business needs and enhance operational efficiency. We face various risks and uncertainties that may affect our ability to meet market demand and respond to competitive actions, which underscores the need for effective IT governance and resource allocation. The integration of technology into our business processes is critical for achieving operational flexibility and maintaining market agility. Our investments in external research and technologies complement and strengthen our own efforts, reflecting a strategic resource allocation that enhances our capabilities. The management continuously evaluates our liquidity and capital resources to ensure we can adequately finance our capital requirements, including investments in IT infrastructure that support our operations. The firm recognizes that delays in product launches and regulatory approval processes can significantly impact our business performance and market-based performance, necessitating a focus on actionable investments and strategic management practices. Our ability to provide data and information to users with appropriate levels of accuracy, timeliness, reliability, security, confidentiality, connectivity, and access is essential for meeting changing business needs and directions. The evolving landscape of digital technologies and the increasing complexity of market dynamics require a strong emphasis on IT effectiveness and the integration of technology capabilities into our strategic decisions. We anticipate that continued investment in our technology portfolio will enhance our operational efficiency and support our organizational transformation initiatives. The firm’s capability to manage information processing capacity and ensure information security is vital for maintaining competitive positioning in the market. As we expand our manufacturing capacity to meet existing and expected demand, we are committed to leveraging our IT resources to facilitate communication and coordination across our operations. The ongoing evaluation of our business strategies in light of regulatory changes and competitive forces will guide our investment choices and operational decisions, ensuring alignment with our organizational goals and enhancing our overall performance.